Epoetin-alfa/stanozolol

Reactions Weekly ◽

10.1007/s40278-021-06967-6 ◽

2021 ◽

Vol 1885 (1) ◽

pp. 208-208

Keyword(s):

Download Full-text

Conversion from Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients: Effectiveness and Variability in Anemia Treatment

Journal of Renal Nutrition ◽

10.1053/j.jrn.2020.01.010 ◽

2020 ◽

Vol 30 (2) ◽

pp. 173

Keyword(s):

Darbepoetin Alfa ◽

Hemodialysis Patients ◽

Epoetin Alfa ◽

Anemia Treatment

Download Full-text

Epoetin alfa in patients not on chemotherapy [ndash ] Canadian data

Seminars in Oncology ◽

10.1053/sonc.2002.33538 ◽

2002 ◽

Vol 29 (3 Suppl 8) ◽

pp. 75-80 ◽

Author(s):

Ian Quirt ◽

Christine Robeson ◽

Cathy Y. Lau ◽

Michael Kovacs ◽

Susan Burdette-Radoux ◽

...

Keyword(s):

Epoetin Alfa ◽

Download Full-text

Therapie mit Epoetin-alfa-Biosimilar im integrierten Anämiemanagement (KATIA) - Ergebnisse einer multizentrischen, prospektiven Beobachtungsstudie

Dialyse aktuell ◽

10.1055/s-0031-1271932 ◽

2010 ◽

Vol 14 (S 01) ◽

pp. S28-S29

Keyword(s):

Download Full-text

Epoetin Alfa

10.32388/5b4ugo ◽

2020 ◽

Author(s):

Keyword(s):

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of epoetin alfa in critically ill patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1096937.555994 ◽

2008 ◽

Author(s):

Lena Napolitano

Keyword(s):

Critically Ill ◽

Critically Ill Patients ◽

Efficacy And Safety ◽

Download Full-text

Faculty Opinions recommendation of Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958874.793463586 ◽

2012 ◽

Author(s):

Antonio Risitano ◽

Fabiana Perna

Keyword(s):

Myelodysplastic Syndrome ◽

Combined Treatment ◽

Epoetin Alfa ◽

Download Full-text

Faculty Opinions recommendation of Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718040707.793482078 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Adjuvant Chemotherapy ◽

Randomized Clinical Trial ◽

Epoetin Alfa ◽

Download Full-text

Faculty Opinions recommendation of Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718109732.793483872 ◽

2013 ◽

Author(s):

Davide Cattano

Keyword(s):

Side Effects ◽

Cost Saving ◽

Discrete Event Simulation ◽

Discrete Event ◽

Blood Transfusions ◽

Epoetin Alfa ◽

Potential Cost Saving ◽

Potential Cost ◽

Event Simulation ◽

Discrete Event Simulation Model

Download Full-text

Faculty Opinions recommendation of Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725333767.793504316 ◽

2015 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Systematic Review ◽

Mortality Risk ◽

Darbepoetin Alfa ◽

Meta Analysis ◽

Download Full-text

The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study

Indian Journal of Hematology and Blood Transfusion ◽

10.1007/s12288-021-01458-1 ◽

2021 ◽

Author(s):

Muzeyyen Aslaner Ak ◽

Birsen Sahip ◽

Ayfer Geduk ◽

Mehmer Ali Ucar ◽

Hacer Kale ◽

...

Keyword(s):

Myelodysplastic Syndrome ◽

Clinical Efficacy ◽

Darbepoetin Alfa ◽

Real Life ◽

Low Risk ◽

Epoetin Alfa ◽

Real Life Study

Download Full-text